Warren bill would get feds into generic drug manufacturing

Politico, here. 

Investigation of generic ‘cartel’ expands to 300 drugs

WashingtonPost, here. 

Mylan Tried to ‘Squelch’ EpiPen Rival, Sanofi Says in Lawsuit

Bloomberg, here. 

FTC Charges That Shire ViroPharma Inc. Abused Government Processes Through Serial, Sham Petitioning to Delay Generics and Maintain its Monopoly over Vancocin HCl Capsules

FTC, here. 

Free Trade Agreements Should Promote Generic Competition, Speakers Say At WTO

IP-Watch, here. 

Disclosing the lowest prices for generics to allow comparison-shopping

NYTimes, here.

2nd Circ. Wary Of Anti-Competitive Intent In Namenda Plan

Law360.com, here. 

ACCC v Pfizer Australia

Federal Court of Australia, here. 

No abuse of a dominant position by AstraZeneca

ACM.nl, here. 

High-Cost Generic Drugs — Implications for Patients and Policymakers

J. Alpern, W. Stauffer, and A. Kesselheim, here. 

Justice Department Probes Generic Companies After Price Hike Reports

Blogs.wsj.com, here. 

U.S. Steps Up Probes of Deals to Block Generic Drugs

BusinessWeek.com, here. 

Improper Use of Restricted Drug Distribution Programs May Impede Generic Competition

FTC Amicus Brief, here. 

Italy's contribution to the June 2014 OECD discussions on generic pharmaceuticals and competition

Here. Other documentation on the same topic here. 

Statement of South Africa on Access to Essential Medicines

Keionline.org, here.

Indian government refutes Novartis' allegations of 'discriminatory' patent practices

Economictimes.indiatimes.com, here. 

Sanofi-Aventis sanctionnée pour dénigrement à l'encontre des génériques de Plavix

Autorité de la Concurrence, ici.

EU Commission sends Statement of Objections to J&J and Novartis on delayed entry of generic pain-killer

Press Release, here.

Amici Curiae Professors and AAI on reverse-payment settlements

Here. 

FTC Submits Amicus Brief Explaining that Drug Companies Use “No-Authorized Generic” Agreements to Delay Generic Competition

Ftc.gov, here.